Related Experiment Video
Updated: Apr 5, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Duration of antiplatelet therapy cessation before coronary artery bypass surgery: Relation with platelet count
Sushil Prakash Ambesh1, Paurush Ambesh2, Shantanu Pande3
1Professor, Department of Anaesthesiology and Intensive Care, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, U.P., India.
Insights
Discontinuing clopidogrel before surgery requires personalized timing based on platelet count and lifespan. This study proposes a hypothesis to guide antiplatelet therapy withdrawal for elective procedures.
Area of Science:
- Cardiology
- Pharmacology
- Surgical Planning
Background:
- Current guidelines recommend a 5-day clopidogrel discontinuation before elective coronary artery bypass grafting.
- Individual patient platelet counts vary significantly, potentially making a fixed 5-day withdrawal period suboptimal.
Discussion:
- This study addresses the lack of data on optimal antiplatelet therapy discontinuation timing for clopidogrel-treated patients undergoing elective surgery.
- A retrospective analysis was used to develop a hypothesis for determining the appropriate duration for clopidogrel withdrawal.
Key Insights:
- The proposed hypothesis considers individual basal platelet counts and platelet lifespan.
- This approach aims to optimize the timing of antiplatelet therapy cessation relative to elective surgical procedures.
Outlook:
- Further validation of this hypothesis is needed to refine clinical practice guidelines.
- Personalized antiplatelet management may improve patient outcomes and reduce surgical risks.
Abstract:
As of now, no study or data is available to determine the period of discontinuation of antiplatelet therapy and the timing of elective surgery in clopidogrel treated patients. The 2011 ACCF/AHA Guidelines have a Class-I recommendation for withdrawing clopidogrel for 5 days before elective coronary artery bypass grafting. However, 5 days period may not suit all patients as platelet count varies from 150 × 10(9)/L to 450 × 10(9)/L. Based on our retrospective data analysis, we have proposed a hypothesis to determine no of days of discontinuation of antiplatelet therapy while taking in consideration the basal count and life-span of platelets.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:27Coronary Artery Disease V: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:23Peripheral Artery Disease V: Postoperative Nursing Management
01:26Angina IV: Management
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...